Switch to: References

Citations of:

Ethics and drug resistance

Bioethics 21 (4):218–229 (2007)

Add citations

You must login to add citations.
  1. Collective Action and Individual Choice.Jonny Anomaly - 2013 - Journal of Medical Ethics 39 (4):752-756.
    Download  
     
    Export citation  
     
    Bookmark   10 citations  
  • Public Health and the Rights of States.A. Miklos - 2009 - Public Health Ethics 2 (2):158-170.
    When exercising their public health powers, states claim various rights against their subjects and aliens. The paper considers whether public health considerations can help justify some of these rights, and explores some constraints on the justificatory force of public health considerations. I outline two arguments about the moral grounds for states’ rights with regard to public health. The principle of fairness emphasizes that those who benefit from public health measures ought to contribute their fair share in upholding them. Alternatively, states’ (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Combating Resistance: The Case for a Global Antibiotics Treaty.Jonny Anomaly - 2010 - Public Health Ethics 3 (1):13-22.
    Download  
     
    Export citation  
     
    Bookmark   18 citations  
  • Idealist Origins: 1920s and Before.Martin Davies & Stein Helgeby - 2014 - In Graham Oppy & Nick Trakakis (eds.), History of Philosophy in Australia and New Zealand. Dordrecht: Springer. pp. 15-54.
    This paper explores early Australasian philosophy in some detail. Two approaches have dominated Western philosophy in Australia: idealism and materialism. Idealism was prevalent between the 1880s and the 1930s, but dissipated thereafter. Idealism in Australia often reflected Kantian themes, but it also reflected the revival of interest in Hegel through the work of ‘absolute idealists’ such as T. H. Green, F. H. Bradley, and Henry Jones. A number of the early New Zealand philosophers were also educated in the idealist tradition (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Property Claims on Antibiotic Effectiveness.Cristian Timmermann - 2021 - Public Health Ethics 14 (3):256–267.
    The scope and type of property rights recognized over the effectiveness of antibiotics have a direct effect on how those claiming ownership engage in the exploitation and stewardship of this scarce resource. We examine the different property claims and rights the four major interest groups are asserting on antibiotics: (i) the inventors, (ii) those demanding that the resource be treated like any other transferable commodity, (iii) those advocating usage restrictions based on good stewardship principles and (iv) those considering the resource (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Harvesting the uncollected fruits of other people’s intellectual labour.Cristian Timmermann - 2017 - Acta Bioethica 23 (2):259-269.
    Intellectual property regimes necessarily create artificial scarcity leading to wastage, both by blocking follow-up research and hindering access to those who are only able to pay less then the actual retail price. After revising the traditional arguments to hinder access to people’s intellectual labour we will examine why we should be more open to allow free-riding of inventive efforts, especially in cases where innovators have not secured the widest access to the fruits of their research and failed to cooperate with (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Antibiotics and Animal Agriculture: The need for global collective action.Jonny Anomaly - 2018 - In Michael Selgelid (ed.), Ethics and Antimicrobial Resistance. Oxford University Press. pp. 297-308.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • The Ethical Significance of Antimicrobial Resistance.Jasper Littmann & A. M. Viens - 2015 - Public Health Ethics 8 (3):209-224.
    In this paper, we provide a state-of-the-art overview of the ethical challenges that arise in the context of antimicrobial resistance, which includes an introduction to the contributions to the symposium in this issue. We begin by discussing why AMR is a distinct ethical issue, and should not be viewed purely as a technical or medical problem. In the second section, we expand on some of these arguments and argue that AMR presents us with a broad range of ethical problems that (...)
    Download  
     
    Export citation  
     
    Bookmark   20 citations  
  • Is Antimicrobial Resistance a Slowly Emerging Disaster?A. M. Viens & Jasper Littmann - 2015 - Public Health Ethics 8 (3):255-265.
    The problem of antimicrobial resistance is so dire that people are predicting that the era of antibiotics may be coming to an end, ushering in a ‘post-antibiotic’ era. A comprehensive policy response is therefore urgently needed. A part of this response will require framing the problem in such a way that adequately reflects its nature as well as encompassing an approach that has the best prospect of success. This paper considers framing the problem as a slowly emerging disaster, including its (...)
    Download  
     
    Export citation  
     
    Bookmark   7 citations  
  • What High-Income States Should Do to Address Industrial Antibiotic Pollution.Erik Malmqvist & Christian Munthe - 2020 - Public Health Ethics 13 (3):275-287.
    Antibiotic resistance is widely recognized as a major threat to public health and healthcare systems worldwide. Recent research suggests that pollution from antibiotics manufacturing is an important driver of resistance development. Using Sweden as an example, this article considers how industrial antibiotic pollution might be addressed by public actors who are in a position to influence the distribution and use of antibiotics in high-income countries with publicly funded health systems. We identify a number of opportunities for these actors to incentivize (...)
    Download  
     
    Export citation  
     
    Bookmark   5 citations  
  • Ethics, tuberculosis and globalization.Michael J. Selgelid - 2008 - Public Health Ethics 1 (1):10-20.
    CAPPE LPO Box 8260 ANU Canberra ACT 2601 Australia Tel: +61 (0)2 6125 4355, Fax: +61 (0)2 6125 6579; Email: michael.selgelid{at}anu.edu.au ' + u + '@' + d + ' '//--> Abstract This article reviews ethically relevant history of tuberculosis and recent developments regarding extensively drug resistant tuberculosis (XDR-TB). It argues that tuberculosis is one of the most important neglected topics in bioethics. With an emphasis on XDR-TB, it examines a range of the more challenging ethical issues associated with tuberculosis: (...)
    Download  
     
    Export citation  
     
    Bookmark   16 citations  
  • (1 other version)Special Issue: Access to Medicines.T. Pogge - 2008 - Public Health Ethics 1 (2):73-82.
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • (1 other version)Access to medicines.Thomas Pogge - 2008 - Public Health Ethics 1 (2):73-82.
    Professor Thomas Pogge, Professorial Fellow, Centre for Applied Philosophy, LPO Box 8260, Canberra. Tel.: +61 261255485; Email: tp6{at}columbia.edu ' + u + '@' + d + ' '//--> Abstract I would pay three million to go into space, says the banker to his attorney. — I wouldn't go if you paid me, the latter laughs, for me the French Riviera is quite exciting enough. Ah, I would pay a million for an extra year of life , the elderly tourist effusively (...)
    Download  
     
    Export citation  
     
    Bookmark   14 citations  
  • The international dimensions of antimicrobial resistance: Contextual factors shape distinct ethical challenges in South Africa, Sri Lanka and the United Kingdom.Eva M. Krockow & Carolyn Tarrant - 2019 - Bioethics 33 (7):756-765.
    Antimicrobial resistance (AMR) describes the evolution of treatment‐resistant pathogens, with potentially catastrophic consequences for human medicine. AMR is driven by the over‐prescription of antibiotics, and could be reduced through consideration of the ethical dimensions of the dilemma faced by doctors. This dilemma involves balancing apparently opposed interests of current and future patients, and unique contextual factors in different countries, which may modify the core dilemma. We describe three example countries with different economic backgrounds and cultures—South Africa, Sri Lanka and the (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Environmental risk and market approval for human pharmaceuticals.Davide Fumagalli - forthcoming - Monash Bioethics Review:1-20.
    This paper contributes to the growing discussion about how to mitigate pharmaceutical pollution, which is a threat to human, animal, and environmental health as well as a potential driver of antimicrobial resistance. It identifies market approval of pharmaceuticals as one of the most powerful ways to shape producer behavior and highlights that applying this tool raises ethical issues given that it might impact patients’ access to medicines. The paper identifies seven different policy options that progressively give environmental considerations increased priority (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Do physicians' legal duties to patients conflict with public health values? The case of antibiotic overprescription.Carl H. Coleman - 2009 - Journal of Bioethical Inquiry 6 (2):181-185.
    Among the many explanations for antibiotic overprescription, some doctors cite the risk of malpractice liability if they deny a patient's request for an antibiotic and the patient's condition worsens. In this paper, I examine the merits of this concern—i.e., whether physicians could, in fact, face malpractice liability for refusing to prescribe an antibiotic when, from a public health perspective, the use of the antibiotic would be considered inappropriate. I conclude that the potential for liability cannot be dismissed entirely, but the (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations